Backtested Scanners
Crash Reversal
71 Hits · last calculated September 23, 2026 Source: price data (daily closing prices) · Market filter active: the list shows 71 hits from US
Methodology & criteria
The buy day AFTER the crash, in the form we back-tested for you. Four stages have to occur in order: a death cross (the 10-day line falls below the 20-day line), then a drop of at least 20 percent from the close on the cross day, then capitulation — at least one daily close 15 percent or more below the stock's own 20-day line — and finally the first daily close back above the 5-day line. That day is the signal. If the price recovers above its 20-day line before the 20 percent mark is reached, the case does not count. The measured rule includes the exit too: sell at the first close 11 percent or more above the entry price, at the latest at the close of the 12th trading day. Across 9,908 trades in 5,008 US stocks since 2010, survivorship-free and after trading costs: median +6.4 percent per trade, hit rate 66.6 percent, 1.87 percentage points ahead of the S&P 500 (robust mean). The other side comes from the same calculation and is shown in the hit list: on crashes of 50 percent or more this short recipe loses against the index (−5.4 percentage points across 1,116 cases), and holding long is no reliable alternative there — a pre-registered follow-up test does show large edges, but strip out the 2020 and 2021 entry years and all four tested long-hold variants fall behind the index. That is why the "Crash Depth" column states how far each hit fell, and a badge marks the cases at 50 percent or more. The stock has to stay tradable: at least $1 unadjusted and at least $1 million of median daily turnover. A hit stays on the list for twelve trading days — as long as the measured trade would still be open. Source: price data.
No global trading filters — this strategy checks the entire stock universe purely against its own criteria (mega caps over $50B included).
🔔 Watch scanner
Hit List
Tip: clicking a column header sorts the table by that column; a second click flips the direction.
| Symbol | Signal Age (Days) | Crash Depth | Earnings | Avg/Y 3Y | Volatility | Stage | Funda Rating | Piotroski | MktCap | Industry | AI Rating | Deep Dive | Deep-Dive Report | Bankruptcy Check | Sector | Price | YTD | 6 Mo. | 1 Year | Off High | Price Target | RS | EPS Rating | ADR 10D | ADR 30D | Beta | P/E | P/E (f) | P/S | P/B | P/FCF | PEG | EV/EBITDA | EBIT Margin | Gross Margin | Net Margin | ROE | ROA | Debt/Eq | Equity Ratio | Sales +/Y | Growth Score | Div. Yield | Payout Ratio | Altman Z | Inst. % | Short % | Analysts |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IONS Ionis Pharmaceuticals Inc | 0 | -20.1 % | 07/29 | +31 % | 44 % | Stage 1 | B 58 | 4 of 9 | 7.6 $ | Biotechnology | – | — | — | 0/3 | Healthcare | 45.80 $ | -3.9 % | +0.0 % | -26.4 % | −9.7 % | +79.1 % | 72 | 16 | 3.3 % | 3.0 % | 0.42 | — | 90.9 | 8.7 | 15.7 | — | 25.70 | 135.8 | -47.7 % | -6.9 % | -64.7 % | -67.6 % | -12.4 % | 4.15 | 14.2 % | +33.9 % | 5 | 0.0 % | 0.0 % | 4.6 | 107.3 % | 16.7 % | 4.1 (26) |
| VRTS Virtus Investment Partners, Inc. | 0 | -20.3 % | 07/24 | -6 % | 36 % | Stage 4 | D 41 | 5 of 9 | 0.9 $ | Asset Management | – | — | — | 0/3 | Financial Services | 130.30 $ | -10.2 % | -10.7 % | -27.6 % | −36.9 % | +15.2 % | 28 | 8 | 4.4 % | 4.1 % | 1.33 | 8.4 | 7.7 | 1.0 | 1.0 | — | 0.56 | 8.7 | — | 41.1 % | 14.5 % | 10.7 % | 2.0 % | 3.10 | — | -8.0 % | 1 | 7.1 % | 39.8 % | 4.5 | 90.2 % | 12.0 % | 2.5 (4) |
| AVXL Anavex Life Sciences Corp | 0 | -21.1 % | 06/30 | -23 % | ⚠ Wildest 10% 94 % | Stage 4 | D 43 | 2 of 9 | 0.2 $ | Biotechnology | – | — | — | 0/3 | Healthcare | 2.50 $ | -27.5 % | -30.1 % | -71.6 % | −82.4 % | +733.3 % | 3 | 42 | 6.5 % | 6.4 % | 1.14 | — | 3.9 | — | 1.9 | — | — | -5.5 | — | — | 0.0 % | -33.6 % | -9.7 % | — | — | — | 2 | 0.0 % | 0.0 % | 18.7 | 43.9 % | 15.6 % | 4.7 (3) |
| EVMN Evommune, Inc. | 0 | -26.0 % | 08/06 | — | – | Stage 2 | D 32 | 4 of 9 | 0.4 $ | Biotechnology | – | — | — | 0/3 | Healthcare | 9.60 $ | +41.6 % | -14.4 % | — | −27.3 % | +141.3 % | 54 | 42 | 10.8 % | 7.9 % | — | — | 0.0 | 36.1 | 1.2 | — | — | 0.0 | — | 100.0 % | 0.0 % | -45.0 % | -32.0 % | 0.03 | — | +85.7 % | 4 | 0.0 % | 0.0 % | 21.3 | 110.8 % | 17.8 % | — |
| FHTX Foghorn Therapeutics Inc | 0 | -20.3 % | 08/04 | -17 % | 75 % | Stage 4 | C 51 | 1 of 9 | 0.2 $ | Biotechnology | – | — | — | 0/3 | Healthcare | 4.20 $ | -23.3 % | -10.0 % | -17.3 % | −42.0 % | +172.5 % | 17 | 42 | 6.5 % | 6.4 % | 2.86 | — | 0.0 | 6.6 | 2,258.5 | — | — | -1.2 | — | -114.6 % | -175.8 % | -470.4 % | -19.9 % | -0.55 | — | +36.8 % | 5 | 0.0 % | 0.0 % | -5.2 | 76.6 % | 6.0 % | 4.5 (8) |
| SRZN Surrozen Inc | 0 | -24.9 % | 08/14 | +56 % | 74 % | Stage 2 | D 38 | 6 of 9 | 0.2 $ | Biotechnology | – | — | — | 0/3 | Healthcare | 17.60 $ | +10.0 % | +12.3 % | +34.6 % | −29.9 % | +165.1 % | 85 | 42 | 8.8 % | 8.2 % | 0.56 | — | 0.0 | 18.0 | 1.8 | — | — | 0.7 | — | -200.4 % | 0.0 % | -62.8 % | -25.4 % | -0.02 | — | -67.4 % | 3 | 0.0 % | 0.0 % | -28.6 | 101.9 % | 22.2 % | 4.5 (2) |
| ARWR Arrowhead Pharmaceuticals Inc | 1 | -20.1 % | 08/06 | +42 % | 61 % | Stage 2 | D 36 | 3 of 9 | 10.1 $ | Biotechnology | – | — | — | 0/3 | Healthcare | 71.90 $ | +20.3 % | +14.8 % | +124.1 % | −6.2 % | +67.2 % | 96 | 58 | 4.9 % | 5.1 % | 1.28 | — | 111.1 | 15.1 | 16.6 | — | — | 27.9 | -191.6 % | 100.0 % | -47.8 % | -42.4 % | -8.1 % | 2.24 | 27.1 % | +23,258.2 % | 7 | 0.0 % | 0.0 % | 5.1 | 88.6 % | 9.3 % | 4.4 (13) |
| BOOT Boot Barn Holdings Inc | 1 | -20.7 % | 07/30 | +40 % | 46 % | Stage 4 | B 64 | 3 of 9 | 4.0 $ | Apparel Retail | – | — | — | 0/3 | Consumer Cyclical | 129.30 $ | -1.6 % | -13.1 % | -29.4 % | −16.7 % | +80.4 % | 37 | 64 | 5.4 % | 5.6 % | 1.70 | 18.0 | 14.9 | 1.7 | 3.1 | 34.7 | 1.72 | 11.2 | 10.6 % | 37.8 % | 10.4 % | 18.4 % | 8.2 % | 0.59 | 49.5 % | +17.9 % | 5 | 0.0 % | 0.0 % | 8.0 | 116.2 % | 12.0 % | 4.7 (15) |
| RH RH | 1 | -20.2 % | — | -17 % | 61 % | Stage 4 | C 51 | 4 of 9 | 2.6 $ | Specialty Retail | – | — | — | 0/3 | Consumer Cyclical | 130.60 $ | -20.9 % | -10.8 % | -43.4 % | −37.8 % | +31.8 % | 20 | 87 | 7.2 % | 6.9 % | 1.86 | — | 21.5 | 0.7 | — | 10.3 | 0.59 | 12.5 | 0.3 % | 42.7 % | 3.2 % | 29.9 % | 3.5 % | — | 1.2 % | +8.1 % | 4 | 0.0 % | 0.0 % | 3.7 | 105.0 % | 52.1 % | 3.7 (20) |
| WHR Whirlpool Corporation | 1 | -21.5 % | 07/27 | -23 % | 50 % | Stage 4 | D 32 | 2 of 9 | 2.2 $ | Furnishings, Fixtures & Appliances | – | — | — | ⚠ 1/3 | Consumer Cyclical | 33.60 $ | -49.2 % | -46.6 % | -59.5 % | −66.3 % | +53.5 % | 4 | 19 | 5.9 % | 5.3 % | 1.15 | — | 15.0 | 0.1 | — | — | 1.04 | 9.1 | 1.3 % | 13.6 % | 1.3 % | 5.5 % | 1.5 % | — | 23.4 % | -6.5 % | 2 | 9.9 % | 74.4 % | 3.8 | 103.4 % | 0.0 % | 2.8 (12) |
| MBC MasterBrand Inc. | 1 | -24.4 % | 08/05 | -8 % | 53 % | Stage 4 | C 46 | 2 of 9 | 0.9 $ | Furnishings, Fixtures & Appliances | – | — | — | 0/3 | Consumer Cyclical | 7.20 $ | -24.3 % | -10.3 % | -47.9 % | −32.4 % | +57.0 % | 18 | 18 | 6.5 % | 6.2 % | 1.43 | — | 43.7 | 0.3 | 0.7 | 12.8 | — | 38.8 | -0.9 % | 26.9 % | -3.5 % | -0.2 % | 1.0 % | 0.97 | 42.4 % | +1.3 % | 3 | 0.0 % | 0.0 % | 6.4 | 78.2 % | 9.2 % | 4.0 (2) |
| CBRL Cracker Barrel Old Country Store | 1 | -21.5 % | — | -14 % | 55 % | Stage 2 | B 55 | 6 of 9 | 1.0 $ | Restaurants | Neutral | — | ⚠ 1/3 | Consumer Cyclical | 45.50 $ | +85.7 % | +107.4 % | +5.9 % | −32.8 % | +2.7 % | 81 | 91 | 6.3 % | 6.9 % | 1.18 | 46.3 | 50.3 | 0.3 | 2.6 | 17.1 | 1.56 | 12.6 | — | 31.6 % | 0.8 % | 5.6 % | -0.1 % | 2.35 | — | +0.4 % | 3 | 2.2 % | 87.0 % | 3.4 | 97.7 % | 38.3 % | 3.0 (8) | |
| PWP Perella Weinberg Partners | 1 | -33.5 % | 08/07 | +37 % | 50 % | Stage 4 | D 43 | 2 of 9 | 1.3 $ | Capital Markets | – | — | — | 0/3 | Financial Services | 13.30 $ | -6.2 % | -11.0 % | -40.1 % | −37.8 % | +73.8 % | 21 | 3 | 5.2 % | 5.2 % | 1.62 | 51.5 | 0.0 | 1.8 | 4.7 | 14.5 | — | 26.2 | — | 96.6 % | 3.2 % | 13.3 % | 4.5 % | -1.18 | — | -14.5 % | 6 | 2.1 % | 50.9 % | 3.2 | 103.1 % | 14.0 % | 3.8 (4) |
| TROX Tronox Holdings PLC | 1 | -25.0 % | 07/29 | -12 % | 77 % | Stage 1 | D 41 | 5 of 9 | 0.8 $ | Chemicals | – | — | — | 0/3 | Basic Materials | 4.40 $ | +62.3 % | +51.4 % | -7.9 % | −35.4 % | +58.4 % | 66 | 77 | 6.4 % | 6.3 % | 0.77 | — | 21.8 | 0.3 | 0.5 | — | — | 60.4 | — | 5.6 % | -19.2 % | -30.8 % | -1.2 % | 2.69 | — | -6.1 % | 4 | 4.6 % | 15.6 % | 4.7 | 75.2 % | 16.8 % | 4.0 (8) |
| MAMA Mama's Creations Inc. | 1 | -24.1 % | — | +181 % | 55 % | Stage 2 | B 73 | 5 of 9 | 0.6 $ | Packaged Foods | Neutral | — | 0/3 | Consumer Defensive | 13.80 $ | +31.5 % | +19.1 % | +26.2 % | −14.1 % | +70.1 % | 88 | 50 | 6.2 % | 5.6 % | 0.56 | 96.6 | 50.5 | 3.1 | 12.0 | 37.3 | — | 29.6 | 5.1 % | 24.3 % | 3.6 % | 14.9 % | 5.3 % | 0.14 | 61.4 % | +39.2 % | 5 | 0.0 % | 0.0 % | 17.7 | 69.4 % | 7.3 % | 4.5 (4) | |
| VRRM Verra Mobility Corp | 1 | -26.7 % | 08/05 | -26 % | ⚠ Wildest 10% 132 % | Stage 4 | D 37 | 5 of 9 | 0.5 $ | Information Technology Services | Uses AI | — | 0/3 | Technology | 3.40 $ | -80.4 % | -80.3 % | -85.6 % | −83.8 % | +105.9 % | 1 | 25 | 7.2 % | 9.5 % | 0.38 | 4.5 | 10.5 | 0.7 | 2.0 | 5.4 | — | 5.7 | — | 55.7 % | 4.4 % | 45.9 % | 9.2 % | 0.27 | — | +11.4 % | 6 | 0.0 % | 0.0 % | 4.8 | 105.6 % | 10.0 % | 4.6 (7) | |
| SPRY ARS Pharmaceuticals, Inc | 1 | -28.8 % | 08/12 | +21 % | 74 % | Stage 3 | C 45 | 3 of 9 | 0.4 $ | Biotechnology | – | — | — | 0/3 | Healthcare | 4.50 $ | -11.8 % | -25.4 % | -55.6 % | −57.6 % | +423.3 % | 46 | 50 | 8.8 % | 7.9 % | 1.00 | — | 0.0 | 3.8 | 10.6 | — | — | -9.9 | — | 58.4 % | -184.2 % | -136.4 % | -48.0 % | 1.57 | — | -5.5 % | 5 | 0.0 % | 0.0 % | -0.6 | 95.5 % | 33.7 % | 4.8 (6) |
| ZUMZ Zumiez Inc | 1 | -26.7 % | — | +2 % | 55 % | Stage 1 | B 55 | 6 of 9 | 0.3 $ | Apparel Retail | – | — | — | 0/3 | Consumer Cyclical | 14.50 $ | -30.9 % | -35.9 % | -31.9 % | −42.6 % | +56.7 % | 25 | 77 | 4.4 % | 5.5 % | 1.00 | — | 31.3 | 0.3 | — | 8.4 | 0.96 | 8.7 | — | 36.1 % | 1.4 % | 4.8 % | 2.2 % | — | — | +4.5 % | 6 | 0.0 % | 0.0 % | 6.7 | 80.9 % | 11.0 % | 3.0 (3) |
| KRUS Kura Sushi USA Inc | 1 | -25.4 % | 07/07 | -15 % | 64 % | Stage 4 | B 68 | 5 of 9 | 0.5 $ | Restaurants | – | — | — | 0/3 | Consumer Cyclical | 37.40 $ | -10.1 % | +7.3 % | -51.3 % | −42.8 % | +82.8 % | 11 | 73 | 7.3 % | 6.8 % | 1.32 | — | 120.5 | 1.6 | 2.2 | 104.1 | — | 44.6 | — | 16.4 % | -0.7 % | -0.9 % | -0.4 % | 0.89 | — | +18.9 % | 5 | 0.0 % | 0.0 % | 4.3 | 93.0 % | 23.0 % | 4.1 (10) |
| JACK Jack in the Box Inc. | 1 | -20.7 % | 08/05 | -29 % | 76 % | Stage 4 | D 31 | 4 of 9 | 0.3 $ | Restaurants | Neutral | — | ⚠ 1/3 | Consumer Cyclical | 13.40 $ | -24.9 % | -31.1 % | -29.5 % | −42.8 % | +51.5 % | 14 | 8 | 10.9 % | 8.8 % | 1.41 | — | 4.8 | 0.2 | 170.5 | — | 0.37 | 254.7 | 13.5 % | 26.7 % | 2.4 % | 0.0 % | 4.2 % | — | -36.2 % | -6.8 % | 3 | 0.0 % | 0.0 % | 1.5 | 99.6 % | 31.2 % | 3.5 (20) | |
| FOA Finance of America Companies Inc | 1 | -39.7 % | 08/04 | +3 % | 46 % | Stage 4 | D 36 | 3 of 9 | 0.1 $ | Credit Services | – | — | — | 0/3 | Financial Services | 15.10 $ | -13.8 % | +20.2 % | -42.8 % | −26.8 % | +113.8 % | 36 | 10 | 7.9 % | 5.4 % | 1.66 | 6.8 | 2.9 | 0.1 | 0.4 | — | — | 0.0 | — | 71.1 % | -0.1 % | 15.6 % | -0.1 % | 88.46 | — | +9.2 % | 5 | 0.0 % | 0.0 % | 2.7 | 57.0 % | 10.0 % | 3.0 (1) |
| RFIL RF Industries Ltd | 1 | -25.7 % | — | +133 % | ⚠ Wildest 10% 89 % | Stage 2 | B 72 | 7 of 9 | 0.1 $ | Electrical Equipment & Parts | Neutral | — | 0/3 | Industrials | 8.40 $ | +265.4 % | +254.2 % | +5.0 % | −6.1 % | +107.3 % | 97 | 61 | 12.2 % | 9.9 % | 1.30 | 64.3 | 9.9 | 1.1 | 2.4 | 29.1 | — | 18.3 | — | 35.1 % | 2.8 % | 3.9 % | 4.3 % | 0.65 | — | +24.3 % | 5 | 0.0 % | 0.0 % | 6.5 | 44.1 % | 7.8 % | 5.0 (1) | |
| STRO Sutro Biopharma | 1 | -31.1 % | 08/06 | -14 % | ⚠ Wildest 10% 89 % | Stage 2 | D 30 | 6 of 9 | 0.3 $ | Biotechnology | – | — | — | 0/3 | Healthcare | 16.10 $ | +152.3 % | +210.2 % | +84.4 % | −32.6 % | +184.5 % | 96 | 42 | 9.7 % | 10.4 % | 1.49 | — | 10.0 | 5.8 | 1.2 | — | — | 41.7 | — | -216.7 % | 0.0 % | -1,810.0 % | -36.1 % | -0.20 | — | +65.2 % | 2 | 0.0 % | 0.0 % | -9.7 | 86.8 % | 11.0 % | 3.7 (10) |
| GPCR Structure Therapeutics Inc. | 1 | -28.9 % | — | — | ⚠ Wildest 10% 94 % | — | D 25 | 2 of 9 | 2.6 $ | Biotechnology | – | — | — | 0/3 | Healthcare | 36.90 $ | -25.1 % | -34.0 % | +51.0 % | −44.4 % | +202.2 % | — | — | — | — | -1.52 | — | 0.0 | — | 2.0 | — | — | -13.5 | 0.0 % | — | 0.0 % | -20.2 % | -15.0 % | 0.00 | 95.7 % | — | — | 0.0 % | 0.0 % | 33.0 | 96.1 % | 11.2 % | 4.6 (14) |
| MLTX MoonLake Immunotherapeutics | 1 | -38.6 % | — | — | ⚠ Wildest 10% 242 % | — | D 35 | 1 of 9 | 1.1 $ | Biotechnology | – | — | — | 0/3 | Healthcare | 13.40 $ | +25.9 % | +5.3 % | -75.7 % | −73.2 % | +126.5 % | — | — | — | — | 1.04 | — | 0.0 | — | 4.7 | — | — | -41.5 | 0.0 % | — | 0.0 % | -67.5 % | -32.4 % | 0.25 | 71.7 % | — | — | 0.0 % | 0.0 % | 4.7 | 79.0 % | 11.6 % | 4.8 (16) |
| ELVR Sayona Mining Limited | 1 | -21.0 % | — | — | ⚠ Wildest 10% 87 % | — | B 59 | 2 of 9 | 0.9 $ | Other Industrial Metals & Mining | – | — | — | 0/3 | Basic Materials | 44.50 $ | +13.5 % | +12.9 % | +104.7 % | −41.7 % | — | — | — | — | — | 0.86 | — | 4.8 | — | 1.6 | — | — | 11.7 | -5.8 % | 113.5 % | 21.3 % | -26.3 % | 4.4 % | 0.18 | 64.4 % | +11.2 % | 3 | 0.0 % | 0.0 % | — | 8.1 % | — | — |
| CSIQ Canadian Solar Inc | 1 | -20.8 % | — | — | ⚠ Wildest 10% 95 % | — | E 24 | 1 of 9 | 0.8 $ | Solar | – | — | — | 0/3 | Technology | 11.80 $ | -33.2 % | -24.5 % | -7.5 % | −52.7 % | +51.2 % | — | — | — | — | 1.51 | — | 21.5 | 0.1 | 0.3 | — | 0.16 | 302.7 | 6.8 % | 17.6 % | -3.7 % | -2.9 % | 0.4 % | 2.61 | 18.5 % | -6.7 % | 3 | 0.0 % | 0.0 % | 0.5 | 61.8 % | 33.0 % | 3.6 (11) |
| JKS JinkoSolar Holding Company Limited | 1 | -24.7 % | — | — | 62 % | — | D 29 | 3 of 9 | 0.6 $ | Solar | – | — | — | 0/3 | Technology | 10.50 $ | -35.4 % | -41.8 % | -54.7 % | −45.5 % | +92.9 % | — | — | — | — | 0.48 | — | 6.5 | 0.1 | 0.2 | — | 0.14 | 176.7 | -4.8 % | 4.8 % | -5.9 % | -19.2 % | -2.5 % | 3.03 | 13.0 % | -29.0 % | 4 | 14.4 % | 388.5 % | — | 35.9 % | 9.3 % | 3.1 (7) |
| ALOY REalloys Inc. | 1 | -21.3 % | — | — | ⚠ Wildest 10% 144 % | — | D 30 | 4 of 9 | 0.6 $ | Other Industrial Metals & Mining | – | — | — | 0/3 | Basic Materials | 9.00 $ | +57.5 % | +6.3 % | +42.0 % | −50.7 % | +82.8 % | — | — | — | — | 0.63 | — | 0.0 | 219.3 | 0.0 | — | — | 0.0 | -12,416.0 % | 29.7 % | 0.0 % | -470.6 % | -60.7 % | 0.10 | 65.1 % | -5.3 % | 3 | 0.0 % | 0.0 % | 166.4 | 17.2 % | — | — |
| BTQ BTQ Technologies Corp. | 1 | -23.5 % | — | — | ⚠ Wildest 10% 137 % | — | E 22 | 2 of 9 | 0.4 $ | Software - Infrastructure | – | — | — | 0/3 | Technology | 2.70 $ | -13.5 % | +39.7 % | -57.5 % | −68.7 % | +196.4 % | — | — | — | — | -15.50 | — | 0.0 | 5,513.4 | 20.9 | — | — | 0.0 | -62,099.0 % | — | 0.0 % | -282.6 % | -229.2 % | 0.00 | 93.6 % | -52.7 % | 4 | 0.0 % | 0.0 % | — | 15.2 % | — | — |
| FJET Starfighters Space, Inc. | 1 | -52.9 % Crash of 50% or More | — | — | – | — | D 39 | 4 of 9 | 0.1 $ | Aerospace & Defense | – | — | — | 0/3 | Industrials | 1.90 $ | -64.8 % | -20.8 % | — | −87.0 % | — | — | — | — | — | — | — | 0.0 | — | 4.5 | — | — | 0.0 | 0.0 % | — | 0.0 % | -200.7 % | -59.1 % | 0.06 | 87.7 % | — | — | 0.0 % | 0.0 % | 36.1 | 20.5 % | 10.2 % | — |
| COLL Collegium Pharmaceutical Inc | 2 | -25.0 % | 08/06 | +17 % | 45 % | Stage 4 | B 60 | 8 of 9 | 0.7 $ | Drug Manufacturers - Specialty & Generic | Uses AI | — | 0/3 | Healthcare | 22.80 $ | -25.2 % | -27.4 % | -35.6 % | −31.4 % | +118.1 % | 30 | 16 | 4.5 % | 4.0 % | 0.72 | — | 3.3 | 0.9 | — | 2.2 | — | 4.3 | — | 89.5 % | 5.9 % | 27.4 % | 5.8 % | — | — | +23.6 % | 7 | 0.0 % | 0.0 % | 5.7 | 127.9 % | 22.3 % | 4.2 (5) | |
| FIP FTAI Infrastructure Inc. | 2 | -23.6 % | 08/06 | +16 % | 69 % | Stage 4 | D 38 | 4 of 9 | 0.4 $ | Conglomerates | Neutral | — | — | 0/3 | Industrials | 3.30 $ | +1.7 % | -8.6 % | -32.5 % | −38.1 % | +242.7 % | 25 | 42 | 6.2 % | 6.5 % | 1.89 | — | 83.3 | 0.6 | 19.1 | — | — | 57.5 | — | 40.0 % | -83.4 % | -61.1 % | 0.8 % | 3.91 | — | +51.6 % | 4 | 4.0 % | 0.0 % | 3.1 | 86.4 % | 26.8 % | 4.7 (3) |
| IMUX Immunic Inc | 2 | -20.7 % | 08/06 | +0 % | 79 % | Stage 2 | D 42 | 5 of 9 | 0.1 $ | Biotechnology | – | — | — | ⚠ 1/3 | Healthcare | 10.80 $ | +182.2 % | +163.9 % | +28.2 % | −4.4 % | +326.6 % | 92 | 42 | 6.7 % | 8.8 % | 1.41 | — | 0.0 | — | — | — | — | 0.2 | — | — | 0.0 % | -142.9 % | -66.8 % | — | — | -100.0 % | — | 0.0 % | 0.0 % | -2.1 | 46.9 % | 11.6 % | 4.7 (7) |
| CYD China Yuchai International Limited | 2 | -22.3 % | — | — | 54 % | — | A 79 | 8 of 9 | 1.3 $ | Auto Manufacturers | – | — | — | 0/3 | Consumer Cyclical | 35.10 $ | +31.7 % | -6.3 % | -11.6 % | −21.7 % | +96.3 % | — | — | — | — | 1.42 | 12.1 | 9.4 | 0.2 | 0.9 | — | 0.37 | 2.0 | 6.7 % | 17.9 % | 2.8 % | 6.4 % | 2.2 % | 0.21 | 30.0 % | +25.4 % | 7 | 2.5 % | 0.0 % | — | 26.9 % | 2.2 % | 4.0 (2) |
| LYEL Lyell Immunopharma Inc | 2 | -25.0 % | — | — | 82 % | — | E 18 | 1 of 9 | 0.3 $ | Biotechnology | – | — | — | 0/3 | Healthcare | 11.20 $ | -51.7 % | -36.0 % | -15.3 % | −61.5 % | +238.2 % | — | — | — | — | -0.05 | — | 0.0 | — | 1.1 | — | — | 0.3 | -1,183,425.0 % | 100.0 % | 0.0 % | -93.3 % | -34.2 % | 0.04 | 73.0 % | -41.0 % | 3 | 0.0 % | 0.0 % | -5.5 | 57.0 % | 5.4 % | 2.8 (4) |
| BNAI Brand Engagement Network Inc | 2 | -39.3 % | — | — | ⚠ Wildest 10% 255 % | — | C 52 | 4 of 9 | 0.0 $ | Software - Infrastructure | – | — | — | ⚠ 1/3 | Technology | 7.00 $ | +557.3 % | -34.8 % | +126.7 % | −75.8 % | +150.0 % | — | — | — | — | 0.46 | — | 0.0 | 98.0 | 6.0 | — | — | -6.8 | -3,196.2 % | 100.0 % | 0.0 % | -152.5 % | -31.4 % | 0.61 | 22.6 % | +175.7 % | 4 | 0.0 % | 0.0 % | -3.3 | 17.1 % | 8.0 % | 4.0 (1) |
| ANVS Annovis Bio Inc | 2 | -42.9 % | — | — | ⚠ Wildest 10% 94 % | — | D 30 | 2 of 9 | 0.1 $ | Biotechnology | – | — | — | ⚠ 1/3 | Healthcare | 1.30 $ | -45.4 % | -24.1 % | -45.7 % | −62.9 % | +854.5 % | — | — | — | — | 1.24 | — | 0.0 | — | 17.6 | — | — | -3.6 | 0.0 % | — | 0.0 % | -301.1 % | -142.4 % | 0.00 | 79.9 % | — | — | 0.0 % | 0.0 % | -3.1 | 24.1 % | 12.9 % | 4.3 (4) |
| PL Planet Labs PBC | 3 | -24.3 % | — | +276 % | ⚠ Wildest 10% 92 % | Stage 2 | C 54 | 3 of 9 | 6.1 $ | Aerospace & Defense | – | — | — | 0/3 | Industrials | 16.90 $ | +44.7 % | +53.9 % | +53.7 % | −48.8 % | +100.0 % | 95 | 42 | 9.1 % | 10.3 % | 2.11 | — | 0.0 | 16.1 | 13.5 | 260.0 | — | -6.7 | -30.5 % | 55.5 % | -95.1 % | -84.0 % | -5.1 % | 1.10 | 35.5 % | +25.9 % | 7 | 0.0 % | 0.0 % | 0.6 | 80.5 % | 9.7 % | 4.5 (11) |
| DYN Dyne Therapeutics Inc | 3 | -32.0 % | 07/27 | +31 % | 76 % | Stage 3 | D 31 | 2 of 9 | 2.8 $ | Biotechnology | – | — | — | 0/3 | Healthcare | 17.10 $ | +3.6 % | +4.5 % | +30.4 % | −17.6 % | +105.5 % | 79 | 42 | 6.5 % | 6.2 % | 1.08 | — | 0.0 | — | 3.3 | — | 0.19 | -8.9 | 0.0 % | — | 0.0 % | -58.9 % | -39.0 % | 0.02 | 80.1 % | -100.0 % | 2 | 0.0 % | 0.0 % | 6.1 | 115.5 % | 14.2 % | 4.4 (14) |
| QDEL Quidel Corporation | 3 | -20.6 % | 08/04 | -29 % | ⚠ Wildest 10% 92 % | Stage 4 | D 40 | 3 of 9 | 0.8 $ | Medical Devices | – | — | — | 0/3 | Healthcare | 10.90 $ | -58.2 % | -36.9 % | -62.3 % | −62.0 % | +32.1 % | 4 | 7 | 10.7 % | 8.9 % | 0.68 | — | 9.6 | 0.3 | — | — | 2.06 | 22.8 | — | 44.9 % | -39.2 % | -50.0 % | 0.4 % | — | — | -1.9 % | 2 | 0.0 % | 0.0 % | 2.4 | 124.1 % | 28.1 % | 3.9 (8) |
| NB NioCorp Developments Ltd. | 3 | -21.7 % | 07/10 | -1 % | ⚠ Wildest 10% 97 % | Stage 4 | D 44 | 3 of 9 | 0.5 $ | Other Industrial Metals & Mining | Neutral | — | 0/3 | Basic Materials | 3.70 $ | -22.3 % | -13.3 % | -36.6 % | −64.7 % | +200.5 % | 55 | 42 | 5.6 % | 7.2 % | 0.22 | — | 0.0 | — | 1.2 | — | — | -3.3 | 0.0 % | — | 0.0 % | -24.5 % | -8.7 % | 0.00 | 64.6 % | — | — | 0.0 % | 0.0 % | 18.7 | 35.3 % | 6.6 % | 4.0 (2) | |
| ANNX Annexon Inc | 3 | -22.5 % | 08/13 | +17 % | 74 % | Stage 1 | D 37 | 1 of 9 | 0.7 $ | Biotechnology | – | — | — | 0/3 | Healthcare | 4.20 $ | +5.2 % | +7.5 % | +47.6 % | −28.3 % | +263.9 % | 82 | 42 | 7.4 % | 6.6 % | 1.22 | — | 0.0 | — | — | — | — | -2.5 | — | — | 0.0 % | -87.6 % | -51.5 % | — | — | — | 2 | 0.0 % | 0.0 % | -5.2 | 102.7 % | 17.9 % | 4.6 (8) |
| OSS One Stop Systems Inc | 3 | -25.3 % | 08/06 | +164 % | ⚠ Wildest 10% 105 % | Stage 2 | C 50 | 7 of 9 | 0.2 $ | Computer Hardware | Sells AI | — | — | 0/3 | Technology | 9.50 $ | +137.0 % | +129.3 % | +35.9 % | −22.4 % | +123.5 % | 96 | 5 | 9.0 % | 9.0 % | 1.46 | — | 125.0 | 4.9 | 5.1 | — | — | 285.5 | — | 49.3 % | 3.3 % | -3.3 % | -0.8 % | 0.03 | — | -41.1 % | 5 | 0.0 % | 0.0 % | 15.7 | 41.0 % | 19.1 % | 4.7 (3) |
| BRUN Boost Run Inc. | 3 | -34.2 % | — | — | ⚠ Wildest 10% 93 % | — | C 46 | 5 of 9 | 1.1 $ | Software - Infrastructure | – | — | — | ⚠ 1/3 | Technology | 17.10 $ | +47.2 % | +66.5 % | +42.5 % | −52.5 % | +148.5 % | — | — | — | — | — | — | 0.0 | — | 234.2 | — | — | 0.0 | -24.4 % | 89.5 % | -173.7 % | -208.3 % | -15.2 % | 2.87 | 10.5 % | +238.8 % | 5 | 0.0 % | 0.0 % | 9.1 | 35.2 % | — | — |
| CRBU Caribou Biosciences Inc | 3 | -21.9 % | — | — | 72 % | — | D 44 | 3 of 9 | 0.1 $ | Biotechnology | – | — | — | 0/3 | Healthcare | 1.30 $ | +6.3 % | +3.7 % | -30.6 % | −40.5 % | +812.1 % | — | — | — | — | 2.28 | — | 0.0 | 12.8 | 1.2 | — | — | -36.9 | -1,096.4 % | -735.6 % | 0.0 % | -83.5 % | -36.9 % | 0.01 | 69.7 % | +11.7 % | 2 | 0.0 % | 0.0 % | -4.6 | 44.5 % | 12.1 % | 4.3 (9) |
| PTHS Pelthos Therapeutics Inc. | 3 | -23.9 % | — | — | 78 % | — | D 37 | 3 of 9 | 0.1 $ | Biotechnology | – | — | — | ⚠ 1/3 | Healthcare | 23.10 $ | -7.7 % | +29.7 % | -29.9 % | −23.5 % | +148.3 % | — | — | — | — | 3.05 | — | 0.0 | 1.9 | 2.3 | — | — | -3.6 | -120.0 % | 75.6 % | -199.5 % | -333.8 % | -50.0 % | 0.83 | 29.8 % | — | 1 | 0.0 % | 0.0 % | -0.5 | 45.4 % | 5.1 % | — |
| COO The Cooper Companies, Inc | 4 | -24.9 % | — | -10 % | 33 % | Stage 4 | B 57 | 5 of 9 | 10.7 $ | Medical Instruments & Supplies | – | — | — | 0/3 | Healthcare | 55.30 $ | -19.3 % | -13.5 % | -20.6 % | −21.4 % | +21.3 % | 25 | 69 | 2.7 % | 2.9 % | 0.82 | 48.2 | 11.1 | 2.5 | 1.3 | 15.7 | 0.51 | 13.6 | -2.9 % | 65.9 % | 13.5 % | 2.9 % | 2.7 % | 0.57 | 66.0 % | +5.1 % | 5 | 0.0 % | 0.0 % | 7.8 | 107.1 % | 5.3 % | 4.1 (19) |
| TNDM Tandem Diabetes Care Inc | 4 | -23.5 % | 08/05 | -14 % | 75 % | Stage 1 | B 55 | 5 of 9 | 1.2 $ | Medical Devices | – | — | — | 0/3 | Healthcare | 17.50 $ | -34.4 % | -29.6 % | +40.2 % | −46.9 % | +66.9 % | 11 | 18 | 5.8 % | 7.5 % | 1.56 | — | 116.3 | 1.1 | — | — | — | 345.7 | — | 56.0 % | -6.1 % | -65.7 % | -2.7 % | — | — | +7.9 % | 4 | 0.0 % | 0.0 % | 2.9 | 117.8 % | 22.6 % | 3.7 (21) |
| HQ Horizon Quantum Holdings Ltd. | 4 | -35.9 % | — | — | ⚠ Wildest 10% 126 % | — | E 21 | 2 of 9 | 0.8 $ | Software - Infrastructure | – | — | — | 0/3 | Technology | 15.70 $ | -3.9 % | +5.6 % | +18.6 % | −67.5 % | +33.1 % | — | — | — | — | 0.33 | — | 0.0 | — | 19.5 | — | — | 0.0 | -12,174,603.0 % | 100.0 % | 0.0 % | -543.8 % | -20.7 % | 4.79 | 0.9 % | — | 4 | 0.0 % | 0.0 % | — | 26.3 % | 7.8 % | — |
| KRMN Karman Holdings Inc. | 5 | -27.5 % | 08/06 | — | 73 % | Stage 4 | B 65 | 5 of 9 | 4.4 $ | Aerospace & Defense | – | — | — | 0/3 | Industrials | 33.50 $ | -36.6 % | -41.7 % | -46.8 % | −60.9 % | +167.1 % | 8 | 50 | 6.8 % | 7.3 % | — | 136.0 | 44.1 | 7.5 | 10.2 | — | — | 34.8 | 15.5 % | 41.7 % | 6.3 % | 7.9 % | 5.1 % | 2.14 | 28.6 % | +36.6 % | 6 | 0.0 % | 0.0 % | 5.3 | 97.1 % | 11.5 % | 4.8 (5) |
| NAVN Navan, Inc. | 5 | -24.7 % | — | — | – | Stage 2 | B 66 | 5 of 9 | 5.0 $ | Software - Application | – | — | — | 0/3 | Technology | 21.00 $ | +24.6 % | +49.7 % | — | −11.9 % | +44.2 % | 89 | 50 | 7.0 % | 7.2 % | — | — | 93.5 | 6.1 | 3.5 | 140.6 | — | 0.0 | — | 72.6 % | -42.1 % | -52.9 % | -8.7 % | 0.14 | — | +30.8 % | 5 | 0.0 % | 0.0 % | 4.7 | 60.1 % | 33.4 % | — |
| QTTB Q32 Bio Inc | 5 | -21.1 % | — | — | ⚠ Wildest 10% 144 % | — | B 66 | 3 of 9 | 0.3 $ | Biotechnology | – | — | — | 0/3 | Healthcare | 10.60 $ | +364.2 % | +268.7 % | +465.2 % | −27.9 % | +298.6 % | — | — | — | — | -0.38 | 3.4 | 0.0 | 5.9 | 3.0 | — | — | 6.0 | 39.9 % | 73.3 % | 62.9 % | 72.1 % | 14.7 % | 0.25 | 68.0 % | — | 6 | 0.0 % | 0.0 % | 11.9 | 70.1 % | 17.0 % | 3.7 (3) |
| PINS Pinterest Inc | 6 | -20.7 % | 08/06 | -9 % | 55 % | Stage 4 | B 55 | 4 of 9 | 10.3 $ | Internet Content & Information | – | — | — | 0/3 | Communication Services | 18.40 $ | -24.6 % | -16.3 % | -45.9 % | −51.2 % | +54.7 % | 14 | 5 | 5.5 % | 5.4 % | 0.89 | 41.7 | 9.0 | 2.3 | 3.9 | 8.1 | 0.27 | 34.7 | -3.3 % | 79.5 % | 5.5 % | 8.9 % | 3.5 % | 0.51 | 61.4 % | +15.8 % | 8 | 0.0 % | 0.0 % | 8.0 | 116.7 % | 13.0 % | 4.4 (42) |
| EVCM EverCommerce Inc | 6 | -36.4 % | 08/05 | -7 % | 65 % | Stage 4 | B 59 | 7 of 9 | 1.4 $ | Software - Application | – | — | — | 0/3 | Technology | 8.10 $ | -27.2 % | -18.9 % | -30.3 % | −39.4 % | +42.9 % | 14 | 42 | 5.9 % | 5.8 % | 0.84 | — | 10.4 | 2.4 | — | 15.1 | 0.35 | 14.4 | — | 77.8 % | 5.7 % | 3.4 % | 2.7 % | — | — | -15.7 % | 4 | 0.0 % | 0.0 % | 3.7 | 92.3 % | 12.0 % | 3.9 (11) |
| UIS Unisys Corporation | 6 | -22.8 % | 07/29 | -4 % | 64 % | Stage 2 | D 37 | 3 of 9 | 0.2 $ | Information Technology Services | – | — | — | 0/3 | Technology | 2.50 $ | +31.2 % | +34.9 % | -39.3 % | −29.7 % | +92.5 % | 71 | 17 | 5.8 % | 7.6 % | 1.89 | — | 2.1 | 0.1 | 11.9 | 2.8 | 0.14 | 4.3 | — | 28.6 % | -21.7 % | 0.0 % | 2.5 % | -2.55 | — | -2.9 % | 4 | 0.0 % | 0.0 % | -1.4 | 81.8 % | 8.5 % | 3.0 (1) |
| ADSK Autodesk Inc | 7 | -20.7 % | — | -2 % | 38 % | Stage 4 | B 72 | 9 of 9 | 46.1 $ | Software - Application | – | — | — | ⚠ 1/3 | Technology | 219.60 $ | -36.2 % | -34.5 % | -32.3 % | −42.4 % | +42.0 % | 8 | 91 | 4.0 % | 4.3 % | 1.31 | 31.2 | 18.4 | 5.9 | 14.2 | 16.3 | 0.88 | 19.9 | 29.5 % | 92.5 % | 21.1 % | 50.4 % | 11.5 % | -2.37 | 26.7 % | +17.5 % | 8 | 0.0 % | 0.0 % | 3.9 | 97.5 % | 4.5 % | 4.3 (32) |
| GRPN Groupon Inc | 7 | -20.3 % | 08/05 | +68 % | 74 % | Stage 3 | D 34 | 3 of 9 | 0.8 $ | Internet Content & Information | Uses AI | — | ⚠ 1/3 | Communication Services | 21.30 $ | -4.8 % | +29.9 % | -2.1 % | −46.9 % | +63.1 % | 38 | 86 | 9.3 % | 8.9 % | 0.24 | — | 21.1 | 1.6 | 16.2 | 27.3 | 14.66 | 17.4 | — | 90.7 % | -25.3 % | -15.2 % | 0.8 % | -5.02 | — | +1.2 % | 4 | 0.0 % | 0.0 % | -7.0 | 148.1 % | 47.3 % | 4.0 (4) | |
| CRDO Credo Technology Group Holding Ltd | 9 | -29.5 % | 09/02 | +487 % | ⚠ Wildest 10% 96 % | Stage 2 | A 85 | 7 of 9 | 35.8 $ | Semiconductors | Sells AI | — | 0/3 | Technology | 192.60 $ | +89.0 % | +63.6 % | +17.3 % | −13.2 % | +74.9 % | 96 | 93 | 10.5 % | 11.3 % | 3.23 | 73.5 | 23.9 | 22.5 | 16.5 | 81.7 | — | 49.5 | 35.7 % | 67.1 % | 33.8 % | 34.4 % | 16.1 % | 0.01 | 89.9 % | +205.7 % | 9 | 0.0 % | 0.0 % | 19.7 | 75.9 % | 4.0 % | 4.6 (13) | |
| CIEN Ciena Corp | 10 | -20.6 % | — | +340 % | 73 % | Stage 2 | A 77 | 7 of 9 | 52.2 $ | Communication Equipment | – | — | — | 0/3 | Technology | 368.60 $ | +96.6 % | +99.3 % | +164.6 % | −24.0 % | +46.0 % | 97 | 98 | 7.8 % | 7.5 % | 1.31 | 122.0 | 37.0 | 8.7 | 18.0 | 72.6 | 0.53 | 47.4 | 15.2 % | 44.1 % | 10.9 % | 15.5 % | 7.7 % | 0.67 | 47.9 % | +18.8 % | 5 | 0.0 % | 0.0 % | 5.8 | 98.0 % | 3.7 % | 4.1 (16) |
| ENOV Enovis Corp | 10 | -27.7 % | 08/06 | -22 % | 64 % | Stage 4 | C 54 | 6 of 9 | 1.1 $ | Medical Devices | – | — | — | 0/3 | Healthcare | 18.40 $ | -20.6 % | -18.0 % | -44.3 % | −40.2 % | +115.4 % | 15 | 89 | 5.0 % | 5.5 % | 1.43 | — | 4.6 | 0.5 | 0.7 | 16.7 | 1.90 | 22.4 | — | 61.3 % | -48.0 % | -55.4 % | 1.2 % | 0.96 | — | +6.7 % | 5 | 0.0 % | 0.0 % | 1.9 | 119.7 % | 18.8 % | 4.6 (11) |
| AIIO Robo.ai Inc. | 10 | -38.6 % | — | — | ⚠ Wildest 10% 202 % | — | D 33 | 2 of 9 | 0.3 $ | Auto Manufacturers | – | — | — | ⚠ 1/3 | Consumer Cyclical | 1.60 $ | +877.1 % | +1,622.5 % | -95.4 % | −47.2 % | — | — | — | — | — | 2.02 | — | 0.0 | 10.1 | 0.5 | — | — | -27.0 | -175,808.1 % | 1.3 % | -213.6 % | 0.0 % | -149.3 % | — | -1,323.9 % | -92.1 % | 2 | 0.0 % | 0.0 % | -225.3 | 0.2 % | 1.2 % | — |
| FINV FinVolution Group | 10 | -27.3 % | — | — | 51 % | — | C 48 | 3 of 9 | 0.8 $ | Credit Services | – | — | — | 0/3 | Financial Services | 3.30 $ | -15.3 % | -20.2 % | -54.8 % | −53.0 % | +69.3 % | — | — | — | — | 0.39 | 2.7 | 3.7 | 0.4 | 0.3 | 7.8 | — | 0.2 | 43.7 % | 70.2 % | 14.5 % | 13.8 % | 14.1 % | 0.08 | 65.1 % | +1.0 % | 3 | 9.3 % | 11.7 % | — | 51.8 % | 4.7 % | 5.0 (8) |
| BURL Burlington Stores Inc | 11 | -23.7 % | 08/27 | +37 % | 41 % | Stage 2 | B 66 | 4 of 9 | 16.2 $ | Apparel Retail | – | — | — | 0/3 | Consumer Cyclical | 256.90 $ | +15.0 % | +9.0 % | -4.3 % | −7.8 % | +58.1 % | 64 | 61 | 3.7 % | 4.3 % | 1.42 | 28.3 | 19.4 | 1.3 | 9.4 | 33.8 | 2.99 | 13.5 | 5.9 % | 44.1 % | 5.9 % | 39.1 % | 6.2 % | 3.28 | 18.8 % | +8.8 % | 5 | 0.0 % | 0.0 % | 5.1 | 106.0 % | 5.8 % | 4.3 (18) |
| AGX Argan Inc | 11 | -21.6 % | — | +629 % | 76 % | Stage 2 | A 77 | 5 of 9 | 5.6 $ | Engineering & Construction | Uses AI | — | — | 0/3 | Industrials | 371.30 $ | +135.6 % | +141.6 % | +46.5 % | −4.8 % | +49.6 % | 96 | 86 | 7.0 % | 7.0 % | 0.57 | 32.8 | 16.6 | 4.7 | 10.9 | 10.2 | — | 23.2 | 15.6 % | 20.7 % | 15.1 % | 38.5 % | 10.0 % | — | 36.8 % | +8.1 % | 8 | 0.7 % | 15.8 % | 8.1 | 108.9 % | 7.8 % | 4.0 (2) |
| LCID Lucid Group Inc | 11 | -29.3 % | 08/04 | -30 % | 83 % | Stage 4 | D 40 | 1 of 9 | 1.7 $ | Auto Manufacturers | – | — | — | 0/3 | Consumer Cyclical | 4.30 $ | -50.9 % | -44.9 % | -79.6 % | −79.7 % | +88.6 % | 2 | 42 | 8.0 % | 7.4 % | 0.81 | — | 0.0 | 1.1 | 2.6 | — | — | -2.1 | — | -100.6 % | -249.2 % | -97.6 % | -30.7 % | 1.55 | — | +67.6 % | 5 | 0.0 % | 0.0 % | -6.5 | 61.9 % | 45.8 % | 2.9 (15) |
| ELMD Electromed Inc | 11 | -32.7 % | 08/25 | +80 % | 50 % | Stage 2 | B 74 | 7 of 9 | 0.2 $ | Medical Devices | Neutral | — | 0/3 | Healthcare | 27.60 $ | +32.3 % | +47.0 % | +9.0 % | −2.3 % | +85.1 % | 87 | 81 | 5.2 % | 5.7 % | 0.46 | 25.9 | 20.2 | 3.1 | 4.9 | 24.8 | 0.35 | 13.3 | — | 78.5 % | 15.3 % | 21.7 % | 14.5 % | — | — | +17.0 % | 9 | 0.0 % | 0.0 % | 15.6 | 59.1 % | 2.4 % | 5.0 (3) | |
| LFMD LifeMD Inc | 11 | -21.4 % | 08/04 | +6 % | 78 % | Stage 3 | D 31 | 5 of 9 | 0.2 $ | Health Information Services | – | — | — | 0/3 | Healthcare | 3.30 $ | +33.4 % | +5.0 % | -49.3 % | −70.9 % | +153.9 % | 27 | 42 | 7.7 % | 7.2 % | 2.04 | — | 12.9 | 0.8 | 11.0 | — | — | 26.8 | — | 87.5 % | 0.1 % | -238.5 % | -18.9 % | 0.41 | — | -8.7 % | 6 | 0.0 % | 0.0 % | -8.7 | 37.1 % | 18.0 % | 4.6 (8) |
| MNSO Miniso Group Holding Ltd | 11 | -21.8 % | — | — | 37 % | — | B 56 | 5 of 9 | 2.7 $ | Specialty Retail | – | — | — | 0/3 | Consumer Cyclical | 9.10 $ | -35.8 % | -36.9 % | -61.9 % | −54.8 % | +73.2 % | — | — | — | — | 0.09 | 9.6 | 7.5 | 0.8 | 1.7 | — | — | 9.2 | 26.8 % | 45.0 % | 5.4 % | 18.8 % | 7.3 % | 0.82 | 37.1 % | +22.8 % | 6 | 7.7 % | 5.1 % | — | 4.9 % | 2.4 % | 4.4 (18) |
| FRMI Fermi Inc. | 12 | -23.0 % | — | — | – | — | E 21 | — | 3.3 $ | REIT - Specialty | – | — | 0/3 | Real Estate | 5.10 $ | — | — | — | — | +242.5 % | — | — | — | — | — | — | 0.0 | — | 3.6 | — | — | 0.0 | — | — | 0.0 % | — | 0.0 % | — | — | — | — | 0.0 % | 0.0 % | — | — | 12.4 % | — | |
| QFIN 360 Finance Inc | 12 | -32.9 % | — | — | 59 % | — | D 38 | 5 of 9 | 1.0 $ | Credit Services | – | — | — | 0/3 | Financial Services | 7.90 $ | -33.6 % | -21.7 % | -71.4 % | −63.3 % | +87.6 % | — | — | — | — | 0.57 | 1.4 | 3.3 | 0.4 | 0.3 | 1.6 | — | 0.0 | 27.5 % | 52.9 % | 22.3 % | 21.3 % | 6.6 % | 0.16 | 42.3 % | +8.8 % | 7 | 15.3 % | 4.7 % | — | 61.8 % | 2.6 % | 4.8 (12) |
Price Chart
Quarterly Figures
No quarterly data available.
Frequently Asked Questions
The buy day AFTER the crash, in the form we back-tested for you. Four stages have to occur in order: a death cross (the 10-day line falls below the 20-day line), then a drop of at least 20 percent from the close on the cross day, then capitulation — at least one daily close 15 percent or more below the stock's own 20-day line — and finally the first daily close back above the 5-day line. That day is the signal.
All scanners are recalculated daily across the entire stock universe — most recently on September 23, 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).
Currently, 71 stocks pass this scanner's criteria (as of September 23, 2026).
No global trading filters — this strategy checks the entire stock universe purely against its own criteria (mega caps over $50B included).
The scanner looks for the buy day AFTER a crash. Four stages have to occur in order. First, a death cross: the 10-day line falls below the 20-day line, on a daily-close basis. Second, a real crash: from the close on the cross day to the lowest subsequent close, the stock loses at least 20%. If it recovers above its 20-day line before that, the case does not count — that was a dip, not a capitulation. Third, the capitulation itself: at least one day closes 15% or more below its own 20-day line. And fourth, the buy: the first daily close back above the 5-day line, no earlier than the capitulation day and after the 20% mark has been reached. That day is the signal. The stock also has to stay tradable: at least $1 unadjusted on the cross day and at the low, and at least $1 million of median daily turnover from 30 trading days before the cross through the buy. The measured rule also includes an exit no scanner can enforce: sell at the first close 11% or more above the entry price, at the latest at the close of the 12th trading day. We back-tested this rule across 9,908 trades in 5,008 US stocks since 2010, survivorship-free — delisted names stay in the data set. Under a realistic cost model (0.5%, 0.2%, or 0.1% per side by trading liquidity, while the benchmark deliberately carries no costs at all): median +6.39% per trade, robust mean +3.70%, hit rate 66.6%, an edge over the S&P 500 of +3.47 percentage points on the median and +1.87 on the robust mean. Two things belong to that honestly. First, the edge only comes from an early entry AND a short exit combined — buy only above the 20-day line and the rule beats the index — measured on the winsorized mean — in none of 1,500 tested exit variants, and stop-losses worsen the result across all 50 tested distances. Second, on crashes of 50% or more the picture reverses: 1,116 such cases came in 5.44 percentage points behind the index. Holding long is no reliable alternative there: a pre-registered follow-up test does show large edges, but strip out the 2020 and 2021 entry years and all four tested long-hold variants fall behind the index. The "Crash Depth" column and the "Crash of 50% or More" badge show exactly that on every hit. All figures and caveats are in the study. A hit is a find, not a buy signal. Source: price data.
Related scanners
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.